Related Experiment Videos
Hepatocellular carcinoma in Africans
1Royal Free Hospital, London, United Kingdom.
The Italian Journal of Gastroenterology
|March 1, 1992
Summary
Hepatocellular carcinoma (HCC) is common in Africa, affecting younger individuals. High rates of Hepatitis B (HBsAg) and C (anti-HCV) infections contribute to this endemic disease.
Area of Science:
- Hepatology
- Oncology
- Public Health
Background:
- Hepatocellular carcinoma (HCC) is highly prevalent in Africa, with a notable incidence in males.
- The disease typically presents at a younger age compared to European or Chinese populations.
- Hepatitis B surface antigen (HBsAg) positivity is common in African HCC patients, particularly younger ones.
Purpose of the Study:
- To summarize the epidemiological characteristics and risk factors of Hepatocellular Carcinoma (HCC) in Africa.
- To highlight the challenges in managing HCC within the African healthcare context.
Main Methods:
- Review of existing literature and epidemiological data on HCC in Africa.
- Analysis of patient demographics, viral markers, and environmental co-factors.
Main Results:
- Male incidence of HCC ranges from 20-100,000 per annum.
- Approximately 30% of patients test positive for anti-Hepatitis C virus (HCV).
- Hepatitis B virus (HBV) and HCV infections are significant contributors, potentially leading to cirrhosis.
Conclusions:
- Chronic HBV and HCV infections are key drivers of HCC in Africa.
- Environmental factors like aflatoxin may act as co-carcinogens.
- Low resection rates and limited screening for small tumors hinder effective HCC management in Africa.